![John Castle](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
John Castle
Direttore Tecnico/Scientifico/R&S presso
MONTE ROSA THERAPEUTICS, INC.
Profilo
John Castle is currently Chief Data & Information Officer at Monte Rosa Therapeutics, Inc. Formerly, Dr. Castle was Associate Vice President-Translational Medicine at Agenus, Inc. from 2017 to 2020, Chief Scientific Officer at Achilles Therapeutics UK Ltd. from 2017 to 2018, Director-Computational Medicine at BioNTech SE from 2009 to 2014, Associate Director at Rosetta Inpharmatics LLC, Director at Encompass Northwest, Director at Cadence Biomedical, Inc., and Director-Biomark Development Center at The Johannes Gutenberg University of Mainz.
Education includes a doctorate from the University of Washington, undergraduate degrees from William Marsh Rice University and Massachusetts Institute of Technology, a doctorate from Massachusetts Institute of Technology, and an MBA from Harvard Business School.
Posizioni attive di John Castle
| Società | Posizione | Inizio |
|---|---|---|
| MONTE ROSA THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | - |
Precedenti posizioni note di John Castle
| Società | Posizione | Fine |
|---|---|---|
| AGENUS INC. | Corporate Officer/Principal | 01/04/2020 |
Achilles Therapeutics UK Ltd.
 Achilles Therapeutics UK Ltd. BiotechnologyHealth Technology Develops personalized vaccines and adoptive T cell therapies to treat metastatic cancer | Direttore Tecnico/Scientifico/R&S | 01/01/2018 |
| BIONTECH SE | Corporate Officer/Principal | 01/11/2014 |
The Johannes Gutenberg University of Mainz
 The Johannes Gutenberg University of Mainz Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Rosetta Inpharmatics LLC
 Rosetta Inpharmatics LLC BiotechnologyHealth Technology Develops and implements drug discovery technology | Corporate Officer/Principal | - |
Formazione di John Castle
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
17
Relazioni di 1° grado
12
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 12 |
|---|---|
Agenus, Inc.
 Agenus, Inc. BiotechnologyHealth Technology Engages in the development and commercialization of technologies to treat cancers and infectious diseases | Health Technology |
Rosetta Inpharmatics LLC
Rosetta Inpharmatics LLC BiotechnologyHealth Technology Develops and implements drug discovery technology | Health Technology |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rice University
 Rice University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
The Johannes Gutenberg University of Mainz
The Johannes Gutenberg University of Mainz Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BioNTech SE
 BioNTech SE BiotechnologyHealth Technology Develops immunotherapies and mRNA-based vaccines to treat cancer & infectious diseases | Health Technology |
Encompass Northwest
 Encompass Northwest Services to the Health IndustryHealth Services Provides individual and family social services and programs | Health Services |
Cadence Biomedical, Inc.
 Cadence Biomedical, Inc. Medical DistributorsDistribution Services Provides medical devices for mobility impairments | Distribution Services |
Harvard Business School
 Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Achilles Therapeutics UK Ltd.
Achilles Therapeutics UK Ltd. BiotechnologyHealth Technology Develops personalized vaccines and adoptive T cell therapies to treat metastatic cancer | Health Technology |
Monte Rosa Therapeutics, Inc.
 Monte Rosa Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops molecular glue degrader medicines for oncology, autoimmune and inflammatory diseases | Health Technology |
